Dosage & Reconstitution Guide
KLOW Peptide Blend Dosage & Reconstitution Guide
A clear educational guide covering KLOW blend reconstitution, syringe unit conversions, gradual protocol examples, supplies, storage, injection technique, tissue repair research notes and safety considerations.
Quickstart Highlights
- Blend: KLOW
- Common vial size: 80mg total blend
- Common components: TB-500 10mg, BPC-157 10mg, KPV 10mg and GHK-Cu 50mg
- Example reconstitution: 3.0mL bacteriostatic water
- Total concentration: approximately 26.7mg/mL
- Component concentrations: TB-500, BPC-157 and KPV each around 3.33mg/mL; GHK-Cu around 16.7mg/mL
- U-100 syringe maths: 1 unit = 0.01mL = approximately 267mcg total blend
- Common example cycle: 8-12 weeks, with optional extension to 16 weeks
- Storage after mixing: refrigerate at 2-8°C and use within 14-28 days
What is KLOW?
KLOW is a multi-peptide research blend combining TB-500, BPC-157, KPV and GHK-Cu. It is commonly discussed in relation to tissue repair, inflammation pathways, wound healing, collagen support and regeneration-focused research.
The blend brings together four different mechanisms: TB-500 for cell migration and angiogenesis research, BPC-157 for tendon, ligament and tissue repair pathways, KPV for anti-inflammatory pathway discussions, and GHK-Cu for collagen, elastin and skin-related tissue remodelling research.
KLOW Reconstitution Example
The example below is based on an 80mg KLOW vial mixed with 3.0mL bacteriostatic water.
Reconstitution Maths
80mg total blend ÷ 3.0mL = 26.67mg/mL total blend
26.67mg/mL = 26,667mcg/mL total blend
1 unit on a U-100 syringe = 0.01mL
26,667mcg/mL × 0.01mL = approximately 267mcg total blend per unit
Syringe Math Reference
- TB-500: 3.33mg/mL = approximately 33.3mcg per unit
- BPC-157: 3.33mg/mL = approximately 33.3mcg per unit
- KPV: 3.33mg/mL = approximately 33.3mcg per unit
- GHK-Cu: 16.67mg/mL = approximately 166.7mcg per unit
- 1 unit total: approximately 33.3mcg each of TB-500, BPC-157 and KPV, plus 166.7mcg GHK-Cu
KLOW Unit Conversion Table
Standard Gradual Research Example
Reconstitution Steps
- Confirm the vial size and blend ratio before calculating concentration.
- Draw 3.0mL bacteriostatic water using sterile technique.
- Inject the bacteriostatic water slowly down the inside wall of the vial.
- Avoid blasting the powder directly and avoid creating foam.
- Gently swirl or roll the vial until dissolved.
- Do not shake.
- Label the vial with the reconstitution date and concentration.
- Store refrigerated at 2-8°C, protected from light.
Supplies Needed
KLOW Vials
- 8-week example: approximately 3 × 80mg vials.
- 12-week example: approximately 4 × 80mg vials.
- 16-week example: approximately 5 × 80mg vials.
Insulin Syringes
- Daily example: 7 syringes per week.
- 8 weeks: approximately 56 syringes.
- 12 weeks: approximately 84 syringes.
- 16 weeks: approximately 112 syringes.
- Practical note: 30-unit or 50-unit syringes may be easier to read during the lower-unit starting phase.
Bacteriostatic Water
- Per 80mg vial: approximately 3.0mL bacteriostatic water.
- 8-week example: 3 vials × 3.0mL = 9mL total, so 1 × 10mL bottle may be enough.
- 12-week example: 4 vials × 3.0mL = 12mL total, so 2 × 10mL bottles may be needed.
- 16-week example: 5 vials × 3.0mL = 15mL total, so 2 × 10mL bottles may be needed.
Alcohol Swabs
- Per administration: one swab for the vial stopper and one for the injection site.
- Per week: approximately 14 swabs based on daily administration.
- 8 weeks: around 112 swabs, so 2 × 100-count boxes may be needed.
- 12 weeks: around 168 swabs, so 2 × 100-count boxes may be needed.
- 16 weeks: around 224 swabs, so 3 × 100-count boxes may be needed.
Protocol Overview
- Goal discussed in research: tissue repair, inflammation reduction, regeneration and connective tissue support.
- Schedule example: once-daily subcutaneous administration.
- Example reconstitution: 3.0mL bacteriostatic water per 80mg vial.
- Concentration: approximately 26.7mg/mL total blend.
- Cycle length: 8-12 weeks is commonly discussed, with optional extension to 16 weeks.
- Timing: any consistent time, with injection site rotation.
- Storage: lyophilised frozen, reconstituted refrigerated and protected from freeze-thaw cycles.
How KLOW Works
KLOW combines four peptides with complementary mechanisms that are commonly discussed in tissue repair and inflammation research.
TB-500 is discussed for angiogenesis, cell migration and tissue repair through actin-related pathways. BPC-157 is discussed for tendon, ligament and muscle repair pathways through angiogenesis and growth factor modulation.
KPV is a tripeptide fragment associated with anti-inflammatory signalling, including NF-kB pathway discussions. GHK-Cu is a copper peptide discussed for collagen, elastin, wound healing and gene expression related to tissue remodelling.
Potential Benefits Discussed in Research
- Tissue repair pathway research
- Wound healing research
- Inflammation pathway discussions
- NF-kB and cytokine modulation research
- Collagen and elastin synthesis research
- Angiogenesis and blood flow research
- Musculoskeletal recovery and joint health research
- Skin, connective tissue and regeneration-focused research
Reported Side Effects and Limitations
- Mild injection-site redness or irritation
- Tenderness or bruising at the injection site
- Occasional lightheadedness reported with some peptides due to vasodilatory effects
- Potential sensitivity to copper-containing compounds
- Limited human clinical data
- Most safety observations are based on preclinical or early-stage research
- Not a guaranteed treatment for injury, inflammation, pain, skin ageing or tissue repair
Storage Instructions
- Lyophilised powder: store frozen at around -20°C in dry, dark conditions where possible.
- After reconstitution: refrigerate at 2-8°C.
- Use window: commonly discussed as within 14-28 days after reconstitution.
- Do not freeze after mixing: avoid freezing reconstituted solution.
- Protect from light: keep the vial away from unnecessary light exposure.
- Avoid: heat, sunlight, moisture, contamination and repeated freeze-thaw cycles.
- Practical note: allow vials to reach room temperature before opening to reduce condensation uptake.
Injection Technique Notes
This section is general educational information only. It is not personal injection instruction.
- Use a new sterile insulin syringe for each administration.
- Clean the vial stopper and injection site with alcohol and allow both to dry completely.
- Common subcutaneous sites discussed include abdomen, thighs and upper arms.
- Rotate injection sites systematically to reduce local irritation and lipohypertrophy risk.
- Pinch a skinfold and insert into subcutaneous tissue at an appropriate angle.
- Do not aspirate for subcutaneous injections.
- Inject slowly and steadily.
- Wait a few seconds before withdrawing the needle to help reduce leakage.
- Apply gentle pressure after withdrawal and do not massage the injection site.
- Dispose of used sharps safely in a sharps container.
Lifestyle Factors That May Matter
- Protein intake: a protein-forward diet may support tissue repair and recovery goals.
- Training and mobility: resistance training and mobility work may support musculoskeletal adaptations.
- Sleep: quality sleep supports the body’s natural regenerative processes.
- Stress management: managing stress may support recovery and overall consistency.
- Hydration: staying hydrated may support general metabolic function.
- Tracking: documenting amount, date, site and observations can make tolerance patterns easier to review.
Use the Peptide Calculator
If your vial size, water volume or target amount is different, use the Peptide Hub Australia calculator to work out concentration, mL and syringe units.
Calculate KLOW Units
Enter your vial size, BAC water amount and target amount to calculate concentration and syringe units.
Open Peptide CalculatorWhere to Compare KLOW Suppliers
Peptide Hub Australia does not sell KLOW or any other peptides. We compare Australian peptide vendors, package audits, pricing and supplier information to help users review the market more clearly.
Frequently Asked Questions
How much BAC water do you add to an 80mg KLOW vial?
A common educational example is 3.0mL bacteriostatic water added to an 80mg vial, creating a total concentration of approximately 26.7mg/mL.
How much is 1 unit of KLOW?
If an 80mg vial is mixed with 3.0mL, 1 unit is approximately 267mcg total blend. That includes around 33.3mcg each of TB-500, BPC-157 and KPV, plus around 166.7mcg GHK-Cu.
How many units are used in the starting example?
The gradual example starts at 7.5 units, equal to around 0.075mL.
How many units are used in the higher phase example?
The higher phase example uses 22.5 units, equal to around 0.225mL.
What peptides are usually in KLOW?
KLOW commonly refers to a blend of TB-500, BPC-157, KPV and GHK-Cu.
Is KLOW the same as GLOW?
No. GLOW commonly contains GHK-Cu, TB-500 and BPC-157. KLOW adds KPV and uses a different total blend structure.
Is this a personal dosing recommendation?
No. This page is an educational reconstitution and measurement guide only. It is not medical advice or a personal protocol.
